Consistent with our findings, Fujita et al. also found that serum levels of endostatin are upregulated in GC patients, showing that serum endostatin levels could be an important prognostic biomarker in predicting the survival of patients with metastatic GC [20]. The gene discussed is COL18A1; the disease is gastric cancer.